Nautilus Biotechnology (NAUT) Research & Development (2020 - 2026)

Nautilus Biotechnology (NAUT) has 7 years of Research & Development data on file, last reported at $9.7 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 15.85% year-over-year to $9.7 million; the trailing twelve-month figure through Mar 2026 stood at $39.3 million (down 19.97% YoY), and the FY2025 full-year result was $41.1 million, down 18.56% from the prior year.
• Research & Development improved to $9.7 million in Q1 2026, from $9.6 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $12.9 million in Q1 2024 to a low of $8.9 million in Q2 2022.
• A 5-year average of $11.0 million and a median of $10.9 million in 2023 frame the typical range for Research & Development.
• Across the five-year window, Research & Development surged 99.75% in 2022 and dropped 25.33% in 2025, its largest moves.
• Tracing NAUT's Research & Development over 5 years: stood at $9.6 million in 2022, then jumped by 30.03% to $12.5 million in 2023, then grew by 2.86% to $12.8 million in 2024, then retreated by 25.33% to $9.6 million in 2025, then rose by 1.38% to $9.7 million in 2026.
• Business Quant data shows NAUT's Research & Development at $9.7 million in Q1 2026, $9.6 million in Q4 2025, and $9.6 million in Q3 2025.